Chris James Brennan

Chris James Brennan is a notable inventor based in Oxfordshire, GB. He has made significant contributions to the field of immunomodulation, holding a total of 3 patents. His work focuses on developing novel heterocyclic compounds that have the potential to treat various medical conditions.

Latest Patents

Brennan's latest patents include innovative compounds aimed at immunomodulation. One of his key inventions is related to tetracyclic immunomodulatory compounds. This invention pertains to novel heterocyclic compounds, methods for their preparation, and compositions containing them. These compounds are particularly relevant for clinical treatment of conditions such as rheumatoid arthritis, multiple sclerosis, diabetes, asthma, transplantation, systemic lupus erythematosis, and psoriasis. More specifically, these compounds act as CD80 antagonists, inhibiting the interactions between CD80 and CD28. Another patent focuses on immunomodulatory compounds with similar applications and mechanisms.

Career Highlights

Chris James Brennan is associated with Active Biotech AB, where he continues to advance his research and development efforts. His work has positioned him as a key figure in the field of immunology, contributing to the understanding and treatment of complex medical conditions.

Collaborations

Brennan has collaborated with notable colleagues, including Ian Richard Matthews and Muhammed Kamal Uddin. These collaborations have further enriched his research and innovation efforts.

Conclusion

Chris James Brennan is a distinguished inventor whose work in immunomodulatory compounds has the potential to impact the treatment of various medical conditions. His contributions to the field are significant and continue to evolve.